桂林三金(002275.SZ):玉葉解毒顆粒被列入廣西新冠病毒肺炎中醫藥治療方案(試行第三版)
格隆匯2月25日丨桂林三金(002275.SZ)公佈,2020年2月24日,廣西壯族自治區中醫藥管理局發佈了《廣西壯族自治區新型冠狀病毒肺炎中醫藥治療方案(試行第三版)》。公司全資子公司三金集團湖南三金製藥有限責任公司(“湖南三金”)生產的玉葉解毒顆粒被該治療方案列為中醫藥治療醫學觀察期和臨牀治療期(確診病例)輕型或普通型濕熱藴肺證的推薦用藥。
玉葉解毒顆粒是公司全資子公司湖南三金的獨家專利品種,是國家醫保乙類、OTC目錄乙類品種。產品由玉葉金花、山銀花、菊花、野菊花、崗梅、山芝麻、積雪草七味中藥組成,具有清熱解毒、辛涼解表,清暑利濕,生津利濕的功效。用於外感風熱引起的感冒咳嗽,咽喉炎,口乾,咽喉腫痛,小便短赤,預防中暑。
研究證實,玉葉解毒顆粒具有抗甲1型流感病毒作用;具有廣譜體外抗呼吸道病毒作用,包括甲乙型流感病毒、呼吸道合胞病毒、I型單純皰疹病毒和鼻病毒。玉葉金花單味藥對血清中細胞因子水平具有調節作用,可顯著抑制促炎細胞因子上調,減輕炎性病理損傷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.